Larson Financial Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.24K Sell
97
-10
-9% -$1.07K ﹤0.01% 2555
2026
Q2
$11.9K Buy
107
+55
+106% +$4.97K ﹤0.01% 2299
2026
Q1
$4.52K Sell
52
-25
-32% -$2.43K ﹤0.01% 2655
2025
Q4
$8.24K Buy
77
+49
+175% +$5.2K ﹤0.01% 2227
2025
Q3
$2.83K Buy
+28
New +$2.6K ﹤0.01% 2570

Other funds holding RYTM

Larson Financial Group's RYTM Position: Q3 2026 in Review

Larson Financial Group reduced its Rhythm Pharmaceuticals (RYTM) stake by 9.3% in Q3 2026, selling an estimated $1.07K and leaving 97 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Larson Financial Group first reported a position in RYTM in Q3 2025 and has held it in 5 quarters since. The position peaked at $11.9K in Q2 2026. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Larson Financial Group held 97 shares of Rhythm Pharmaceuticals worth $9.24K as of Q3 2026.
  • Larson Financial Group sold 10 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $1.07K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2555 holding.
  • Larson Financial Group first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Rhythm Pharmaceuticals position peaked at $11.9K in Q2 2026.
  • 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.